Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review

INTRODUCTION: Xylazine, an α2-adrenoceptor agonist sedative commonly used in veterinary medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates have surged in recent years, fueled by an increasingly toxic and synthetic illicit drug supply in North America. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autor principal: Zhu, David T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498612/
https://www.ncbi.nlm.nih.gov/pubmed/37700329
http://dx.doi.org/10.1186/s12954-023-00867-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498612/
https://www.ncbi.nlm.nih.gov/pubmed/37700329
http://dx.doi.org/10.1186/s12954-023-00867-x

Ejemplares similares